Literature DB >> 18619974

Combinatorial optimization of a CD4-mimetic miniprotein and cocrystal structures with HIV-1 gp120 envelope glycoprotein.

François Stricher1, Chih-chin Huang, Anne Descours, Sophie Duquesnoy, Olivier Combes, Julie M Decker, Young Do Kwon, Paolo Lusso, George M Shaw, Claudio Vita, Peter D Kwong, Loïc Martin.   

Abstract

Miniproteins provide a bridge between proteins and small molecules. Here we adapt methods from combinatorial chemistry to optimize CD4M33, a synthetic miniprotein into which we had previously transplanted the HIV-1 gp120 binding surface of the CD4 receptor. Iterative deconvolution of generated libraries produced CD4M47, a derivative of CD4M33 that had been optimized at four positions. Surface plasmon resonance demonstrated fourfold to sixfold improvement in CD4M47 affinity for gp120 to a level about threefold tighter than that of CD4 itself. Assessment of the neutralization properties of CD4M47 against a diverse range of isolates spanning from HIV-1 to SIVcpz showed that CD4M47 retained the extraordinary breadth of the parent CD4M33, but yielded only limited improvements in neutralization potencies. Crystal structures of CD4M47 and a phenylalanine variant ([Phe23]M47) were determined at resolutions of 2.4 and 2.6 A, in ternary complexes with HIV-1 gp120 and the 17b antibody. Analysis of these structures revealed a correlation between mimetic affinity for gp120 and overall mimetic-gp120 interactive surface. A correlation was also observed between CD4- and mimetic-induced gp120 structural similarity and CD4- and mimetic-induced gp120 affinity for the CCR5 coreceptor. Despite mimetic substitutions, including a glycine-to-(d)-proline change, the gp120 conformation induced by CD4M47 was as close or closer to the conformation induced by CD4 as the one induced by the parent CD4M33. Our results demonstrate the ability of combinatorial chemistry to optimize a disulfide-containing miniprotein, and of structural biology to decipher the resultant interplay between binding affinity, neutralization breadth, molecular mimicry, and induced affinity for CCR5.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18619974      PMCID: PMC2625307          DOI: 10.1016/j.jmb.2008.06.069

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  50 in total

1.  Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates.

Authors:  P D Kwong; R Wyatt; S Majeed; J Robinson; R W Sweet; J Sodroski; W A Hendrickson
Journal:  Structure       Date:  2000-12-15       Impact factor: 5.006

2.  Cell biology of virus entry.

Authors:  D S Dimitrov
Journal:  Cell       Date:  2000-06-23       Impact factor: 41.582

3.  Energetics of the HIV gp120-CD4 binding reaction.

Authors:  D G Myszka; R W Sweet; P Hensley; M Brigham-Burke; P D Kwong; W A Hendrickson; R Wyatt; J Sodroski; M L Doyle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

4.  Multiple nonfunctional alleles of CCR5 are frequent in various human populations.

Authors:  C Blanpain; B Lee; M Tackoen; B Puffer; A Boom; F Libert; M Sharron; V Wittamer; G Vassart; R W Doms; M Parmentier
Journal:  Blood       Date:  2000-09-01       Impact factor: 22.113

5.  Design and Evolution of a Miniature Bcl-2 Binding Protein We thank the HHMI Biopolymer/Keck Foundation Biotechnology Resource Laboratory (Yale University School of Medicine, New Haven, CT) for oligonucleotide and peptide synthesis and amino acid analysis and Professor Jennifer Doudna (Yale University) for use of a Perseptive Voyager-DE (MALDI-TOF) mass spectrometer. We are grateful also to Dr. Junying Yuan and Dr. Alexi Degterev (Harvard Medical School) for a generous gift of Bcl-X(L)-His(6) and Stacey E. Rutledge for helpful comments. This work was supported by the National Institutes of Health.

Authors:  Jason W. Chin; Alanna Schepartz
Journal:  Angew Chem Int Ed Engl       Date:  2001-10-15       Impact factor: 15.336

Review 6.  Modulation of protein-protein interactions with small organic molecules.

Authors:  Thorsten Berg
Journal:  Angew Chem Int Ed Engl       Date:  2003-06-06       Impact factor: 15.336

7.  Biotechnological applications of phage and cell display.

Authors:  I Benhar
Journal:  Biotechnol Adv       Date:  2001-02-01       Impact factor: 14.227

8.  Rational engineering of a miniprotein that reproduces the core of the CD4 site interacting with HIV-1 envelope glycoprotein.

Authors:  C Vita; E Drakopoulou; J Vizzavona; S Rochette; L Martin; A Ménez; C Roumestand; Y S Yang; L Ylisastigui; A Benjouad; J C Gluckman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

9.  Rational design of a CD4 mimic that inhibits HIV-1 entry and exposes cryptic neutralization epitopes.

Authors:  Loïc Martin; François Stricher; Dorothée Missé; Francesca Sironi; Martine Pugnière; Philippe Barthe; Rafael Prado-Gotor; Isabelle Freulon; Xavier Magne; Christian Roumestand; André Ménez; Paolo Lusso; Francisco Veas; Claudio Vita
Journal:  Nat Biotechnol       Date:  2002-12-16       Impact factor: 54.908

10.  Antibody neutralization and escape by HIV-1.

Authors:  Xiping Wei; Julie M Decker; Shuyi Wang; Huxiong Hui; John C Kappes; Xiaoyun Wu; Jesus F Salazar-Gonzalez; Maria G Salazar; J Michael Kilby; Michael S Saag; Natalia L Komarova; Martin A Nowak; Beatrice H Hahn; Peter D Kwong; George M Shaw
Journal:  Nature       Date:  2003-03-20       Impact factor: 49.962

View more
  35 in total

Review 1.  HIV-1 gp120 as a therapeutic target: navigating a moving labyrinth.

Authors:  Priyamvada Acharya; Sabrina Lusvarghi; Carole A Bewley; Peter D Kwong
Journal:  Expert Opin Ther Targets       Date:  2015-02-27       Impact factor: 6.902

2.  Exceptionally potent and broadly cross-reactive, bispecific multivalent HIV-1 inhibitors based on single human CD4 and antibody domains.

Authors:  Weizao Chen; Yang Feng; Ponraj Prabakaran; Tianlei Ying; Yanping Wang; Jianping Sun; Camila D S Macedo; Zhongyu Zhu; Yuxian He; Victoria R Polonis; Dimiter S Dimitrov
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

3.  Thermosensitive and mucoadhesive pluronic-hydroxypropylmethylcellulose hydrogel containing the mini-CD4 M48U1 is a promising efficient barrier against HIV diffusion through macaque cervicovaginal mucus.

Authors:  Kawthar Bouchemal; Armelle Aka-Any-Grah; Nathalie Dereuddre-Bosquet; Loïc Martin; Vanessa Lievin-Le-Moal; Roger Le Grand; Valérie Nicolas; Davide Gibellini; David Lembo; Christian Poüs; Armand Koffi; Gilles Ponchel
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

4.  Stabilization of HIV-1 envelope in the CD4-bound conformation through specific cross-linking of a CD4 mimetic.

Authors:  Grégoire Martin; Brian Burke; Robert Thaï; Antu K Dey; Olivier Combes; Oscar H P Ramos; Bernadette Heyd; Anthony R Geonnotti; David C Montefiori; Elaine Kan; Ying Lian; Yide Sun; Toufik Abache; Jeffrey B Ulmer; Hocine Madaoui; Raphaël Guérois; Susan W Barnett; Indresh K Srivastava; Pascal Kessler; Loïc Martin
Journal:  J Biol Chem       Date:  2011-04-12       Impact factor: 5.157

5.  Quaternary structures of HIV Env immunogen exhibit conformational vicissitudes and interface diminution elicited by ligand binding.

Authors:  Carlos G Moscoso; Yide Sun; Selina Poon; Li Xing; Elaine Kan; Loïc Martin; Dominik Green; Frank Lin; Anders G Vahlne; Susan Barnett; Indresh Srivastava; R Holland Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-28       Impact factor: 11.205

6.  Synergism between a CD4-mimic peptide and antibodies elicited by a constrained V3 peptide.

Authors:  Adi Moseri; Subramanyam Tantry; Fa-Xiang Ding; Fred Naider; Jacob Anglister
Journal:  AIDS Res Hum Retroviruses       Date:  2012-12-26       Impact factor: 2.205

7.  Conformation-dependent recognition of HIV gp120 by designed ankyrin repeat proteins provides access to novel HIV entry inhibitors.

Authors:  Axel Mann; Nikolas Friedrich; Anders Krarup; Jacqueline Weber; Emanuel Stiegeler; Birgit Dreier; Pavel Pugach; Melissa Robbiani; Tina Riedel; Kerstin Moehle; John A Robinson; Peter Rusert; Andreas Plückthun; Alexandra Trkola
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

8.  Characterization of a discontinuous epitope of the HIV envelope protein gp120 recognized by a human monoclonal antibody using chemical modification and mass spectrometric analysis.

Authors:  Christine Hager-Braun; Elisabeth O Hochleitner; Miroslaw K Gorny; Susan Zolla-Pazner; Rachelle J Bienstock; Kenneth B Tomer
Journal:  J Am Soc Mass Spectrom       Date:  2010-03-31       Impact factor: 3.109

9.  Interfacial cavity filling to optimize CD4-mimetic miniprotein interactions with HIV-1 surface glycoprotein.

Authors:  Laurence Morellato-Castillo; Priyamvada Acharya; Olivier Combes; Johan Michiels; Anne Descours; Oscar H P Ramos; Yongping Yang; Guido Vanham; Kevin K Ariën; Peter D Kwong; Loïc Martin; Pascal Kessler
Journal:  J Med Chem       Date:  2013-06-11       Impact factor: 7.446

10.  Spontaneous rearrangement of the β20/β21 strands in simulations of unliganded HIV-1 glycoprotein, gp120.

Authors:  Indira H Shrivastava; Kaylee Wendel; Judith M LaLonde
Journal:  Biochemistry       Date:  2012-09-21       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.